Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2026-04-22 @ 7:55 AM
Study NCT ID:
NCT02309450
Status:
WITHDRAWN
Last Update Posted:
2016-02-02
First Post:
2014-10-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study to Assess Efficacy and Safety of a Triple Therapy With Asunaprevir, Daclatasvir, and BMS-791325 in HCV Genotype 4-infected Patients After Failure of Pegylated Interferon-Ribavirin Regimen
Sponsor:
ANRS, Emerging Infectious Diseases
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12
Start Date Type:
None
Primary Completion Date:
2015-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-08
Completion Date Type:
ESTIMATED
First Submit Date:
2014-10-31
First Submit QC Date:
None
Study First Post Date:
2014-12-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-01
Last Update Post Date:
2016-02-02
Last Update Post Date Type:
ESTIMATED